Researchers have identified a stem cell protein that may play an important role in finding cure for blood cancer.
The study, done on mice, suggests a stem cell protein called Asrij is a novel regulator of wild type tumour suppressor p53 stability in hematopoietic stem cells (HSCs).
It could help design targeted therapies for myeloproliferative disease, a group of slow-growing blood cancers, according to researchers, including Maneesha S. Inamdar from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bengaluru.
"We provide a new mouse model resembling myeloproliferative disease and identify a post-translational regulator of wild type p53 essential for maintaining HSC quiescence that could be a potential target for pharmacological intervention," the team said.
According to the study, published in the journal Blood, inactivation of the tumour suppressor p53 is essential for unrestrained growth of cancers. But only 11 per cent of hematological malignancies have mutant p53.
Mechanisms that cause wild type p53 dysfunction and promote leukemia are inadequately deciphered, suggests the study.
The stem cell protein Asrij is misexpressed in several human hematological malignancies and implicated in the p53 pathway and DNA damage response, the team said.
For the study, the team generated the first Asrij null (knockout, KO) in mice and showed they are viable and fertile with no gross abnormalities. However, by six months, they exhibited increased peripheral blood cell counts, splenomegaly and an expansion of bone marrow HSCs with higher myeloid output.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Hina Khan Resumes Work After Cancer Diagnosis. Tara Sutaria, Kusha Kapila And Other Celebs Form Her Cheer Squad US Scientists Decode 125-Year-Old Element That Could Improve Cancer Treatments Hina Khan, Battling Cancer, Shares Video From Her First Shoot After Chemo Session: "Trying To Hide Stitches" Under-Fire Trainee IAS Officer Accuses Pune Collector Of Harassment Trainee IAS Officer Puja Khedkar Recalled To Academy, Training Put On Hold "No Defamatory Remarks Against Governor": High Court To Mamata Banerjee Royal Enfield Guerrilla 450 Launched In India; Prices Start At Rs. 2.39 Lakh Admission Deadline Extended For EWS And Special Needs Children UGC Launches Project To Develop 22,000 Books In Indian Languages Track Latest News Live on NDTV.com and get news updates from India and around the world.